Petter Jaremo

Finspang, E, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Diabetes Type 2: Circulating Phosphatidylserine-Expressing Platelets Regulate Whole Blood Agonist-Evoked Platelet Activity In Vitro.

Diabetes Type 2: Circulating Phosphatidylserine-Expressing Platelets Regulate Whole Blood Agonist-Evoked Platelet Activity In Vitro.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: May 15, 2026

Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c).

Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c).

Journal: Hamostaseologie

Published: January 08, 2026

Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence.

Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: July 22, 2025

Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c).

Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c).

Journal: Hamostaseologie

Published: March 06, 2024

Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses.

Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses.

Journal: Annals of medicine

Published: March 16, 2023

Small procoagulant platelets in diabetes type 2.

Small procoagulant platelets in diabetes type 2.

Journal: Thrombosis research

Published: March 07, 2020

Alzheimer's Disease: Erythrocyte 2,3-diphosphoglycerate Content and Circulating Erythropoietin.

Alzheimer's Disease: Erythrocyte 2,3-diphosphoglycerate Content and Circulating Erythropoietin.

Journal: Current Alzheimer research

Published: March 10, 2019

Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment.

Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment.

Journal: Current Alzheimer research

Published: March 09, 2019

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.

Journal: Journal of Alzheimer's disease : JAD

Published: March 01, 2019

Illness beliefs among patients with chronic widespread pain - associations with self-reported health status, anxiety and depressive symptoms and impact of pain.

Illness beliefs among patients with chronic widespread pain - associations with self-reported health status, anxiety and depressive symptoms and impact of pain.

Journal: BMC psychology

Published: February 21, 2017

Inverse relationship between erythrocyte size and platelet reactivity in elderly.

Inverse relationship between erythrocyte size and platelet reactivity in elderly.

Journal: Platelets

Published: August 26, 2016

Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.

Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.

Journal: Journal of Alzheimer's disease : JAD

Published: May 11, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026